Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II studyRobert I. Haddad, Marshall R. Posner, A. Dimitrios Colevas et al.|Oral Oncology|2003Cited by 262
HER2 Expression in Salivary Gland CarcinomasBonnie S. Glisson, Marshall R. Posner, Corey J. Langer et al.|Clinical Cancer Research|2004Cited by 202
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancerRobert I. Haddad, Roy B. Tishler, Stephen T. Sonis et al.|Cancer|2009Cited by 98
Docetaxel, cisplatin, and 5‐fluorouracil‐based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neckRobert I. Haddad, Marshall R. Posner, A. Dimitrios Colevas et al.|Cancer|2003Cited by 91
A Phase II Clinical and Pharmacodynamic Study of E7070 in Patients with Metastatic, Recurrent, or Refractory Squamous Cell Carcinoma of the Head and NeckRobert I. Haddad, Geoffrey I. Shapiro, Lisa J. Weinstein et al.|Clinical Cancer Research|2004Cited by 67